Found: 20
Select item for more details and to access through your institution.
Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID‐19 prevention.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1908, doi. 10.1111/bjh.19321
- By:
- Publication type:
- Article
Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1333640
- By:
- Publication type:
- Article
Uncovering NOTCH1 as a Promising Target in the Treatment of MLL -Rearranged Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 19, p. 14466, doi. 10.3390/ijms241914466
- By:
- Publication type:
- Article
Time‐dependent analysis of adoptive immunotherapy following sequential FLAMSA‐reduced intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high‐risk myeloid neoplasia.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 244, doi. 10.1111/ejh.13732
- By:
- Publication type:
- Article
Invariante natürliche Killer-T-Zellen: Zelluläre Immunregulatoren mit zytotoxischem Potenzial.
- Published in:
- Der Pathologe, 2020, v. 41, p. 134, doi. 10.1007/s00292-020-00829-1
- By:
- Publication type:
- Article
Oral intake of lipopolysaccharide regulates toll-like receptor 4-dependent granulopoiesis.
- Published in:
- Experimental Biology & Medicine, 2020, v. 245, n. 14, p. 1254, doi. 10.1177/1535370220931043
- By:
- Publication type:
- Article
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1487, doi. 10.3390/cancers12061487
- By:
- Publication type:
- Article
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1342, doi. 10.3390/cancers12051342
- By:
- Publication type:
- Article
Inhibition of effector B cells by ibrutinib in systemic sclerosis.
- Published in:
- Arthritis Research & Therapy, 2020, v. 22, n. 1, p. 1, doi. 10.1186/s13075-020-02153-8
- By:
- Publication type:
- Article
Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1991-y
- By:
- Publication type:
- Article
Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01542
- By:
- Publication type:
- Article
G‐CSF administration prior to donor lymphocyte apheresis promotes anti‐leukaemic effects in allogeneic HCT patients.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 1, p. 60, doi. 10.1111/bjh.15881
- By:
- Publication type:
- Article
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 12, p. 2491, doi. 10.1007/s00277-018-3454-y
- By:
- Publication type:
- Article
Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01817
- By:
- Publication type:
- Article
Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation.
- Published in:
- Clinical Transplantation, 2017, v. 31, n. 7, p. n/a, doi. 10.1111/ctr.12994
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Freeze and Thaw of CD4<sup>+</sup>CD25<sup>+</sup>Foxp3<sup>+</sup> Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0145763
- By:
- Publication type:
- Article
Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086551
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 10, p. 1389, doi. 10.1007/s00277-013-1774-5
- By:
- Publication type:
- Article